Education
About Us
Working with TipRanks
Follow Us
Kintor Pharmaceutical Ltd (HK:9939)
:9939
9939 Stock Chart & Stats
HK$1.88
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$1.88
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.85 - HK$3.10
Previous CloseN/A
Volume545.00K
Average Volume (3M)4.99M
Market Cap
HK$921.92M
Enterprise ValueHK$692.81M
Total Cash (Recent Filing)HK$52.86M
Total Debt (Recent Filing)HK$87.40M
Price to Earnings (P/E)―
Beta1.63
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding468,172,600
10 Day Avg. Volume2,605,850
30 Day Avg. Volume4,990,601
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)1.33
Price to Sales (P/S)78.48
P/FCF Ratio-1.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Kintor Pharmaceutical Ltd News
9939 FAQ
What was Kintor Pharmaceutical Ltd’s price range in the past 12 months?
Kintor Pharmaceutical Ltd lowest stock price was HK$0.85 and its highest was HK$3.10 in the past 12 months.
What is Kintor Pharmaceutical Ltd’s market cap?
Kintor Pharmaceutical Ltd’s market cap is HK$921.92M.
When is Kintor Pharmaceutical Ltd’s upcoming earnings report date?
Kintor Pharmaceutical Ltd’s upcoming earnings report date is Mar 26, 2026 which is in 143 days.
How were Kintor Pharmaceutical Ltd’s earnings last quarter?
Kintor Pharmaceutical Ltd released its earnings results on Aug 28, 2025. The company reported -HK$0.206 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.206.
Is Kintor Pharmaceutical Ltd overvalued?
According to Wall Street analysts Kintor Pharmaceutical Ltd’s price is currently Overvalued.
Does Kintor Pharmaceutical Ltd pay dividends?
Kintor Pharmaceutical Ltd does not currently pay dividends.
What is Kintor Pharmaceutical Ltd’s EPS estimate?
Kintor Pharmaceutical Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kintor Pharmaceutical Ltd have?
Kintor Pharmaceutical Ltd has 468,172,600 shares outstanding.
What happened to Kintor Pharmaceutical Ltd’s price movement after its last earnings report?
Kintor Pharmaceutical Ltd reported an EPS of -HK$0.206 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.37%.
Which hedge fund is a major shareholder of Kintor Pharmaceutical Ltd?
Currently, no hedge funds are holding shares in HK:9939
Kintor Pharmaceutical Ltd Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
78.57%
12-Months-Change
Fundamentals
Return on Equity
-54.87%
Trailing 12-Months
Asset Growth
-45.97%
Trailing 12-Months
Company Description
Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Ltd (9939) is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapies for cancer and androgen receptor-related diseases. The company operates primarily in the biotechnology and pharmaceutical sectors, with a portfolio that includes drug candidates for the treatment of prostate cancer, breast cancer, and other critical conditions.
Technical Analysis
TOT BIOPHARM International Co. Ltd.
―
JW (Cayman) Therapeutics Co. Ltd.
―
Clover Biopharmaceuticals Ltd.
―
Sirnaomics Ltd.
―
Shanghai Haohai Biological Technology Co., Ltd. Class H
―
Options Prices
Currently, No data available
---